Status:
SUSPENDED
Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
Lead Sponsor:
Universidade Positivo
Collaborating Sponsors:
Emory University
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The study aims to demonstrate that a simple intravenous insulin algorithm can be implemented in Latin America and will result in safe and better glucose control in patients with Acute Coronary Syndrom...
Detailed Description
The proposed study is a one center open-label randomized controlled clinical trial.Coronary Intensive Care of one hospital in the city of Curitiba, PR, Brazil will be assessed. Consenting eligible su...
Eligibility Criteria
Inclusion
- Male or female
- Age 18 or older
- Evidence of AMI within the last 24 h (troponin-T \>0.1mcg/l) or electrographic criteria of ST-segment elevation in two limb leads)
- Evidence of Unstable Angina
- Blood glucose \>180mg/dL at admission with or without preexisting diabetes
- Willing to give informed consent
- Access to telephone communications after hospital discharge
Exclusion
- Under 18 years of age
- Pregnant or lactating female
- Diabetes ketoacidosis
- Heart failure
- Cardiogenic shock
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01151176
Start Date
August 1 2012
End Date
December 1 2013
Last Update
June 19 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University School of Medicine
Atlanta, Georgia, United States, 30303
2
Hospital Cruz Vermelha Brasileira-Filial do Estado do Paraná
Curitiba, Paraná, Brazil, 80420-011